The present review focuses primarily on PD, marked by alpha-synuclein (aS) pathology, and on two other specific forms of parkinsonian syndromes: Progressive supranuclear palsy (PSP) and Corticobasal degeneration (CBD), and their pathological hallmark, tau. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.